miR-30 inhibits the progression of osteosarcoma by targeting MTA1

Area of Science:

• Oncology
• Molecular Biology
• Biomarkers

Background:

• MicroRNAs (miRNAs) are emerging as critical regulators in various diseases.
• Limited research exists on the role of specific miRNAs, like miR-30, in osteosarcoma (OS) pathogenesis.
• Understanding miRNA roles is vital for developing novel diagnostic and therapeutic strategies.

Purpose of the Study:

• To investigate the role of miR-30 in the occurrence and development of osteosarcoma.
• To determine the relationship between miR-30 and MTA1 in OS.
• To elucidate the functional impact of the miR-30/MTA1 axis on OS cell behavior.

Main Methods:

• Quantitative PCR (qPCR) and Western blotting were employed to assess miR-30 and MTA1 expression in OS tissues and cell lines.
• Bioinformatic analysis and luciferase reporter assays were used to confirm the interaction between miR-30 and MTA1.
• In vitro functional assays, including proliferation and migration assays, were performed to evaluate the effects of miR-30 and MTA1.

Main Results:

• miR-30 expression was significantly decreased, while MTA1 expression was elevated in OS tissues and cells.
• miR-30 directly targets MTA1, evidenced by bioinformatics predictions and luciferase assays, showing a negative correlation.
• Overexpression of MTA1 counteracted the inhibitory effects of miR-30 on OS cell proliferation and migration.

Conclusions:

• miR-30 acts as a tumor suppressor in osteosarcoma by targeting MTA1.
• The miR-30/MTA1 pathway plays a crucial role in regulating OS cell proliferation and migration.
• miR-30 represents a potential biomarker and therapeutic target for osteosarcoma.